跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,232 条关于
“Kyungdong Pharmaceutical”
全部
13,232
临床试验
528
药物
1,662
机构
2,160
资讯
8,882
上个月
Kyungdong Pharmaceutical and Asimov Complete AI-Driven Cell Line Development for Next-Generation Biosimilar Antibody
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
Merck & Co. to Acquire WuXi Biologics' Vaccine Facility in Ireland for $500 Million
去年
Shandong Xinhua Pharmaceutical Receives Approval for Pentazocine
去年
Strategic Intelligence Solutions Reshape Pharmaceutical Industry Decision-Making
第 1 页,共 889 页
上一页
下一页